Fumitaka Kinugasa Selected Research

FR276457

5/2010	Prevention of renal interstitial fibrosis via histone deacetylase inhibition in rats with unilateral ureteral obstruction.
9/2009	Effect of the immunosuppressant histone deacetylase inhibitor FR276457 in a canine renal transplant model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fumitaka Kinugasa Research Topics

Disease

3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 03/2022 - 12/2021
2	Fibrosis (Cirrhosis) 11/2010 - 05/2010
2	Ureteral Obstruction 11/2010 - 05/2010
1	Glomerulonephritis 03/2022
1	Autoimmune Diseases (Autoimmune Disease) 03/2022
1	Nephritis 03/2022
1	Proteinuria 03/2022
1	Neoplasms (Cancer) 01/2021
1	Vasculitis (Vasculitides) 09/2009
1	Hemorrhage 12/2008

Drug/Important Bio-Agent (IBA)

2	Mycophenolic Acid (Cellcept)FDA LinkGeneric 03/2022 - 11/2010
2	AutoantibodiesIBA 03/2022 - 12/2021
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 11/2010 - 05/2010
2	FR276457IBA 05/2010 - 09/2009
1	AutoantigensIBA 03/2022
1	Immunoglobulin G (IgG)IBA 03/2022
1	cathepsin SIBA 03/2022
1	Fc gamma receptor IIBIBA 01/2022
1	B7-H1 AntigenIBA 01/2021
1	Inosine FDA Link 11/2010
1	Oxidoreductases (Dehydrogenase)IBA 11/2010
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 11/2010
1	N- (2- (6- (4- ethylpiperazin- 1- yl)pyridin- 3- yl)propan- 2- yl)- 2- fluoro- 9- oxo- 9,10- dihydroacridine- 3- carboxamideIBA 11/2010
1	Messenger RNA (mRNA)IBA 05/2010
1	Histone Deacetylase InhibitorsIBA 05/2010
1	Hydroxyproline (4 Hydroxyproline)IBA 05/2010
1	Histone Deacetylases (Histone Deacetylase)IBA 05/2010
1	CollagenIBA 05/2010
1	Tacrolimus (Prograf)FDA LinkGeneric 12/2008

Therapy/Procedure

2	Oral Administration 03/2022 - 11/2010
1	Therapeutics 12/2021